The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback